Bilotto Christopher J. 4

What Happened Christopher J. Bilotto, President & CEO and a director of Diversified Healthcare Trust (NASDAQ: DHC), was awarded 12,401 shares on 2026-06-10 under the issuer's equity compensation plan. The Form 4 reports the shares as an award (transaction code A) and lists the price as N/A, so the filing does not state a dollar value for the grant.

Key Details

• Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (appears timely within the Section 16 reporting window).
• Transaction type/code: Award/Grant (A).
• Shares acquired: 12,401 common shares; price per share: N/A; total value: not disclosed in the filing.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 notes the award was pursuant to the issuer's equity compensation plan. F2 says the total includes 560.894 shares acquired under a dividend reinvestment plan since Mr. Bilotto's last Section 16 filing.

Context This was an equity award as part of executive compensation—not an open-market purchase or sale—so it reflects compensation rather than a direct trading signal. Because no per-share price or total value is provided on the Form 4, investors cannot infer the dollar amount of the grant from the filing alone.